Company profile: Gubra
1.1 - Company Overview
Company description
- Provider of pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs focused on the metabolic space, including obesity, diabetes, NASH, and diabetic complications, with specialization in in vivo pharmacology.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gubra
Q1 Scientific
HQ: Ireland
Website
- Description: Provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q1 Scientific company profile →
Medicus Pharma
HQ: Canada
Website
- Description: Provider of biotechnology research services that accelerate life sciences and biotech companies through FDA clinical trials, via clinical development programs spanning clinical evaluation, regulatory approval, and market introduction. Through Skinject Inc., develops a dissolvable doxorubicin microneedle patch for non-melanoma skin cancer, particularly basal cell carcinoma. Pursues acquisitions and partnerships to expand its drug development pipeline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicus Pharma company profile →
Clinical Trials Laboratory
HQ: United Kingdom
Website
- Description: Provider of outsourcing laboratory services procuring high-quality serum, plasma, blood, and blood cells for clinical research across pharmaceutical, bioanalytical, biotechnology, clinical trials, diagnostic, and drug industries. Offers blood donation services collecting biofluids, leukapheresis for white blood cell collection, and donor recruitment and management to ensure a steady supply of biological specimens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trials Laboratory company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
BCI Pharma
HQ: France
Website
- Description: Provider of kinase inhibitor discovery and development solutions, including a proprietary platform to identify novel, potent and selective kinase inhibitors for various diseases; medicinal chemistry and biology laboratories for design, synthesis and cell-based assay development; a preclinical candidate for peripheral neuropathic pain and psoriasis; and risk-sharing collaborations on kinase research projects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BCI Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gubra
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gubra
2.2 - Growth funds investing in similar companies to Gubra
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gubra
4.2 - Public trading comparable groups for Gubra
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →